Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Carol Lisa Rosenberg, M.D.

Title
Institution
Department
Address
Phone

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R21CA115434 (ROSENBERG, CAROL L) Jan 12, 2007 - Dec 31, 2009
    NIH/NCI
    Genetic Signatures of Preinvasive Breast Disease
    Role: Principal Investigator
  2. S10RR021211 (ROSENBERG, CAROL L) Apr 1, 2005 - Mar 31, 2007
    NIH/NCRR
    PixCell IIe Laser Capture Microdissection Instrument
    Role: Principal Investigator
  3. R01CA081078 (ROSENBERG, CAROL L) Apr 1, 2001 - Mar 31, 2007
    NIH/NCI
    GENETIC ABNORMALITIES EARLY ON THE PATH OF BREAST CANCER
    Role: Principal Investigator
  4. R03CA084551 (ROSENBERG, CAROL L) Sep 21, 1999 - Oct 31, 2000
    NIH/NCI
    GENETIC PROFILE OF BREAST CANCER IN WOMEN EXPOSED IN UTE
    Role: Principal Investigator
  5. K08CA062179 (ROSENBERG, CAROL L) Aug 22, 1994 - Jul 31, 2000
    NIH/NCI
    REVERSIBLE C-MYC GENE DEREGULATION IN TRANSFORMED CELLS
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Ahern TP, Christensen M, Cronin-Fenton DP, Lunetta KL, Søiland H, Gjerde J, Garne JP, Rosenberg CL, Silliman RA, Sørensen HT, Lash TL, Hamilton-Dutoit S. Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2011 Sep; 20(9):1937-43. PMID: 21750172.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  2. Fogh S, Hirsch AE, Langmead JP, Goldberg SI, Rosenberg CL, Taghian AG, Powell SN, Kachnic LA. Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer. Clin Breast Cancer. 2011 Mar; 11(1):39-45. PMID: 21421521.
    Citations: 12     Fields:    Translation:Humans
  3. Lash TL, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Garne JP, Sørensen HT, Hellberg Y, Christensen M, Pedersen L, Hamilton-Dutoit S. CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark. J Natl Cancer Inst. 2011 Mar 16; 103(6):489-500. PMID: 21325141.
    Citations: 24     Fields:    Translation:Humans
  4. Lash TL, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Hamilton-Dutoit S, Garne JP, Ewertz M, Sørensen HT, Pedersen L. Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncol. 2010 Apr; 49(3):305-12. PMID: 20156115.
    Citations: 17     Fields:    Translation:Humans
  5. Lash TL, Rosenberg CL. Evidence and practice regarding the role for CYP2D6 inhibition in decisions about tamoxifen therapy. J Clin Oncol. 2010 Mar 10; 28(8):1273-5. PMID: 20124162.
    Citations: 6     Fields:    Translation:Humans
  6. Stead LA, Lash TL, Sobieraj JE, Chi DD, Westrup JL, Charlot M, Blanchard RA, Lee JC, King TC, Rosenberg CL. Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res. 2009; 11(2):R18. PMID: 19320967.
    Citations: 82     Fields:    Translation:Humans
  7. Lash TL, Pedersen L, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Hamilton-Dutoit S, Garne JP, Ewertz M, Sørensen HT. Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram. Br J Cancer. 2008 Aug 19; 99(4):616-21. PMID: 18665165.
    Citations: 14     Fields:    Translation:Humans
  8. Larson PS, Schlechter BL, King CL, Yang Q, Glass CN, Mack C, Pistey R, de Las Morenas A, Rosenberg CL. CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer. BMC Cancer. 2008 Mar 06; 8:68. PMID: 18325103.
    Citations: 24     Fields:    Translation:Humans
  9. Larson PS, Schlechter BL, de las Morenas A, Garber JE, Cupples LA, Rosenberg CL. Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues. J Clin Oncol. 2005 Dec 01; 23(34):8613-9. PMID: 16314623.
    Citations: 13     Fields:    Translation:Humans
  10. Larson PS, de las Morenas A, Bennett SR, Cupples LA, Rosenberg CL. Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. Am J Pathol. 2002 Jul; 161(1):283-90. PMID: 12107113.
    Citations: 16     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Rosenberg's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (70)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.